PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Flecainide acetate - Arrhythmias
PAD Profile : Flecainide acetate - Arrhythmias
Keywords :
supraventricular arrhythmias, ventricular arrhythmias
Brand Names Include :
Tambocor
Traffic Light Status
Status 1 of 2.
Status :
Blue
Important
Formulations :
- Tablets
Important Information :
Specialist initiation and at least one month supply before transfer to primary care
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 2.
Guidelines
No guidelines returned.
Other Drugs
- Amiodarone hydrochloride
- Propafenone hydrochloride
- Digoxin
- Sotalol hydrochloride
- Atenolol
- Mexiletine hydrochloride
- Bisoprolol fumarate
- Disopyramide
- Esmolol hydrochloride
- Lidocaine
- Metoprolol tartrate
- Procainamide hydrochloride
- Propranolol hydrochloride
- Verapamil hydrochloride
Other Indications
No indications returned.
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
03 May 2017
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
GENERIC Flecainide has been considered by the PCN and has been assigned a BLUE traffic light status.
NOTE - the branded product, Tambocor, was considered BLACK at the PCN in May 2017.
01 July 2015
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The PCN supported the attached updated Amber* Information Sheet.
Associated BNF Codes
02. Cardiovascular System
02.03.02. Drugs for arrhythmias